Wall Street futures are largely unchanged Wednesday and with little corporate news or earnings reports during the ...

This FTSE share has delivered double-digit gains since mid-2024, beating the broader UK blue-chip share index. Can it keep outperforming? The post Up 10% in the past year, can this FTSE 100 share ...

Worries over future of Chancellor hit UK stocks, the pound and bond markets - A sharper fall for the FTSE 250 typified a drab ...

In the bond market, the U.S. 10-year Treasury yield was up 5 basis points at 4.3%. Germany's 10-year yield was unchanged at 2 ...

Vestas Wind Systems A/S was the biggest leader among large stocks during the session, surging 10.1%, and Nibe Industrier AB Series B increased 6.9%. Lundin Mining Corp. rounded out the top three ...

Spirax Group PLC closed 31.96% below its 52-week high of £90.75, which the company reached on August 1st.

Dividend paying companies in your portfolio can provide a reliable income but potentially millions of investors are missing ...

AstraZeneca is reportedly considering moving its listing to the US. Here's why AZN's expected departure is alarming for the ...

U.S. stocks are drifting as Wall Street’s record-breaking rally slows ahead of a highly anticipated report coming Thursday ...

The company's exit from the U.K. market would spark a major index re-weighting, given AstraZeneca is the most valuable ...

Find insight on Deutsche Bank, Sabadell and more in the latest Market Talks covering Financial Services.

London's blue-chip stock index edged higher and the midcap index fell on Wednesday as investors assessed a mixed bag of corporate news, including a media report that AstraZeneca is moving its listing ...